Marijuana legalization is on the rise across the United States. While decriminalization is a noble cause, there are many unintended consequences that the government and private sector struggle to manage. One of the most significant challenges is detecting when someone is under the influence of marijuana. Cannabix Technologies Inc. (CSE: BLO) (OTC: BLOZF) is an innovative company actively developing solutions to address this growing problem.
There’s no doubt that marijuana use causes cognitive impairment. The adverse effects on attention, memory, and learning can last for days or weeks after the acute effects of “getting high” wear off. While low productivity is a concern for businesses, workplace safety is far more significant with life-or-death implications.
Quest Diagnostics, one of the largest drug testing laboratories in the country, recently reported that 4.4 percent of all U.S. workers tested positive for marijuana in 2020. Even worse, 2.2 percent of workers in sensitive industries—like truck driving, pilots, or nuclear power plant workers—tested positive for marijuana.
Commonly used urine drug tests cannot determine if individuals are under the influence at the test time, post-accident data suggests that marijuana may play a role in incidents that prompted a drug test. Pre-employment positivity was just 3.7 percent compared to post-accident positivity of 6.4 percent, pointing strongly toward an impact.
Quest Diagnostics also found that marijuana use was on the rise in states where the drug has been legalized for recreational use. With a growing number of states falling under that umbrella, employers need to find ways to discourage on-the-job marijuana use to prevent accidents and create a better and more productive workplace.
Most marijuana tests do not discern the recency of marijuana consumption and have virtually no correlation to impairment.
The need for real-time tests is evident in industries like long-haul trucking. Everyone agrees that truck drivers should never drive under the influence of marijuana, but a new federal clearinghouse and new regulations allowing hair follicle testing have gone too far. These laws could prevent truckers from using recreational marijuana during their own time. Since the clearinghouse went into effect, the industry has already lost nearly 50,000 drivers.
Long detection window makes urine tests less useful. Source: Cannabix Technologies Inc.
Fortunately, new technologies could open the door to real-time tests. In particular, breath analysis has the potential to detect recent marijuana use. Aerosol particles in exhaled breath are formed from respiratory tract lining fluid that only contains THC for a relatively short period of time (one to three hours), aligning with the peak impairment window.
In addition to more accurate readings, breath analysis is non-invasive and non-intrusive, leading to fewer privacy issues. Furthermore, the inexpensive tests don’t require any nurses or technicians, and they can be completed at the point of care rather than sent to a third-party lab. It’s a far better solution than intrusive and expensive urine or blood tests.
Cannabix Technologies Inc. (CSE: BLO) (OTC: BLOZF) is quickly developing cannabis breathalyzer technologies that would be appropriate for work place and other settings. In addition to securing patents on its unique approaches, the company’s advanced prototypes are already in beta testing in real world situations.
THC Breath Analyzer prototype. Source: Cannabix Technologies Inc.
With a growing need among employers and law enforcement, the company could see a lot of growth if it successfully launches a product into the market.
Marijuana use has become a growing problem in the workplace. Unfortunately, most conventional marijuana testing methods like oral fluid or urine testing do not correlate well with peak impairment and can show detection of THC after several hours or days after use. Recreational cannabis users who are not “high” could experience a false positive, leading to unfair consequences. Fortunately, new technologies aim to improve accuracy and fairness.
Cannabix Technologies Inc. (CSE: BLO) (OTC: BLOZF) is developing THC breath analysis tools that could provide point-of-care solutions that detect marijuana use within a short period of time after consumption. The result is a solution that law enforcement and workplace officials could use to ensure safety and compliance.
For more information, visit the company’s website.
The above article is sponsored content. CannabisFN.com and CFN Media, have been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
大麻合法化在美国各地呈上升趋势。虽然非刑罪化是一项崇高的事业，但有许多意想不到的后果是政府和私营部门努力管理的。最重要的挑战之一是检测某人何时受到大麻的影响。Cannabix Technologies Inc.（CSE：BLO）（OTC：BLOZF）是一家创新型公司，积极开发解决方案来解决这一日益严重的问题。
Cannabix Technologies Inc.（CSE：BLO）（OTC：BLOZF）正在迅速开发适用于工作场所和其他环境的大麻酒精分析仪技术。除了在其独特的方法上获得专利之外，该公司的先进原型已经在现实世界的情况下进行了beta测试。
Cannabix Technologies Inc.（CSE：BLO）（OTC：BLOZF）正在开发四氢大麻酚呼吸分析工具，该工具可以提供护理点解决方案，在吸食大麻后的短时间内检测大麻的使用。其结果是执法部门和工作场所官员可以用来确保安全和合规的解决方案。
本文由CFN Enterprises Inc.（OTCQB：CNFN）发表，该公司是CFN Media的所有者和运营商，CFN Media是行业领先的机构和数字金融媒体网络，致力于新兴的CBD和合法大麻行业。请致电+1(833)420-CNFN了解更多信息。